536 results on '"MIEHLKE, S."'
Search Results
2. Eosinophile Ösophagitis
3. Ösophagus
4. Progress in our understanding of H. pylori infection and gastritis
5. Microscopic colitis: Current status, present and future challenges: Statements of the European Microscopic Colitis Group
6. Letter: multivariate clinical model for eosinophilic oesophagitis - is this generalisable to a general population? Authors’ reply
7. Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis
8. Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis
9. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis
10. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis
11. Präkanzeröse Risikomarker der Helicobacter-pylori-Gastritis
12. Intragastric acidity during administration of generic omeprazole or esomeprazole – a randomised, two-way crossover study including CYP2C19 genotyping
13. Blutstillung
14. Die Laser Capture Mikrodissektion: moderne Analyse molekulargenetischer Alterationen
15. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract
16. Helicobacter pylori und Magenkarzinom Ist eine präventive Interventionsstudie sinnvoll?: Ist eine präventive Interventionsstudie sinnvoll?
17. Treatment of Helicobacter pylori Reinfection
18. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial
19. Induction of Intestinal P-glycoprotein by St Johnʼs Wort Reduces the Oral Bioavailability of Talinolol
20. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin
21. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double-blind, placebo-controlled multicentre trial
22. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide
23. Esomeprazole: potent acid suppression in the treatment of acid-related disorders
24. Time to remission with budesonide in collagenous colitis
25. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two-way crossover study
26. Patients with bioptically proven intestinal GvHD demonstrate extensively increased amounts of mucosa infiltrating perforin+/CD8+ cytotoxic T-cells and a concomitant decrease in Foxp3+ regulatory T (Treg) cells
27. Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland
28. Treatment
29. Genotyping of Nigerian Helicobacter pylori isolates by pulsed-field gel electrophoresis
30. Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance
31. Esomeprazole-Based Triple Therapy with Clarithromycin and Metronidazole is Effective in Eradicating Helicobacter pylori in the Absence of Antimicrobial Resistance – A Prospective, Randomised, Multicenter Trial
32. One-Week Triple Therapy with Esomeprazole, Levofloxacin and Amoxicillin is Effective for Eradication of Helicobacter pylori Sensitive or Resistant to Metronidazole and/or Clarithromycin
33. HELYX Study Part I & II: Treatment of Low-Grade Gastric Non Hodgkinʼs Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages I & II1. Current Status
34. Cure of Gastrointestinal Protein Loss by Helicobacter pylori Eradication with Esomeprazole-Based Triple Therapy in a Patient with Lymphocytic Giant Fold Gastritis
35. Genotyping of Nigerian Helicobacter pylori Isolates by PFGE
36. HELYX Study Part I & II: Treatment of low-grade gastric nonHodgkinʼs lymphoma of mucosa-associated lymphoid tissue (MALT) type stages IE & II1E: 210
37. The selective Cox-2 inhibitor Rofecoxib inhibits cell proliferation of gastric cancer cell lines in a dose-dependent manner: 183
38. α-Catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives
39. HELICOBACTER HEILMANNII - ASSOCIATED PRIMARY GASTRIC LOW GRADE MALT LYMPHOMA - COMPLETE REMISSION AFTER ANTIBACTERIAL TREATMENT
40. COMPLETE REMISSION OF PRIMARY GASTRIC HIGH GRADE MALT LYMPHOMA AFTER CURE OF HELICOBACTER PYLORI INFECTION
41. CURE OF HELICOBACTER PYLORI INFECTION IS ASSOCIATED WITH LONG-TERM REMISSION IN LIMITED STAGES OF LOW-GRADE GASTRIC MALT LYMPHOMA
42. LEPTIN AND ITS RECEPTOR IN NORMAL HUMAN GASTRIC MUCOSA AND IN HELICOBACTER PYLORI-ASSOCIATED GASTRITIS
43. CLINICAL RELEVANCE OF THE HELICOBACTER PYLORI GENE FOR BLOOD GROUP ANTIGEN BINDING ADHESIN (BabA)
44. CORRELATION BETWEEN HELICOBACTER PYLORI cagA, iceA AND vacA GENOTYPES AND EXPRESSION OF GASTRITIS IN PATIENTS WITH GASTRIC CANCER, GASTRIC MALT LYMPHOMA, AND DUODENAL ULCER
45. Orodispersible Budesonid-Tabletten sind überlegen in der Erhaltung und weiteren Verbesserung der Lebensqualität bei erwachsenen Patienten mit eosinophiler Ösophagitis (EoE): Ergebnisse der 48-wöchigen, doppel-blinden, Placebo-kontrollierten Behandlung in der EOS-2 Studie
46. Signifikante Verbesserung der Krankheisaktivität (Microscopic Colitis Disease Activity Index – MCDAI) durch Budesonid bei lymphozytärer Kolitis
47. Wirksamkeit und Verträglichkeit von Menthacarin bei Patienten mit Reizdarmsyndrom – Ergebnisse einer randomisierten, doppelblinden, placebo-kontrollierten Studie
48. Hohe Trennschärfe des 13C-Harnstoffatemtests der zweiten Generation (Diabact) in der Diagnostik der Helicobacter pylori (HP)-Infektion
49. Eine neue orodispersible Budesonid-Tablette ist hoch effektiv für die Remissionsinduktion bei Patienten mit aktiver eosinophiler Ösophagitis – Ergebnisse der 6-wöchigen „open-label“-Behandlung in der EOS-2 Studie
50. Management der hepatischen Enzephalopathie in Deutschland: eine Umfrage unter Gastroenterologen und Allgemeinmedizinern
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.